CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses

Por Corgnac, Stéphanie, Perret, Rachel, Derré, Laurent, Zhang, Lianjun, Stirnemann, Kathrin, Zauderer, Maurice, Speiser, Daniel E., Mach, Jean-Pierre, Romero, Pedro, Donda, Alena
Publicado em 2012

Sustained activation and tumor targeting of NKT cells using a CD1d–anti-HER2–scFv fusion protein induce antitumor effects in mice

Por Stirnemann, Kathrin, Romero, Jackeline F., Baldi, Lucia, Robert, Bruno, Cesson, Valérie, Besra, Gurdyal S., Zauderer, Maurice, Wurm, Florian, Corradin, Giampietro, Mach, Jean-Pierre, MacDonald, H. Robson, Donda, Alena
Publicado em 2008